TABLE 2

Comparison of Subjects With and Without Development of a Severe Complication

Severe Complication, n (%), n = 85No Complication, n (%), n = 156P Value
Age, mo, median37.721.5.16
Gender, % boys49 (57.6)94 (60.3).69
Race
 White39 (46.4)66 (42.3).72
 Black38 (45.2)79 (50.6)
 Other7 (8.3)11 (7.1)
No. in household, mean ± SD4.7 ± 1.74.4 ± 1.5.32
Day care/school attendance43 (51.8)77 (50.7).98
Any high-risk conditiona50 (58.8)79 (50.6).28
 Asthma23 (27.1)35 (22.4).42
 Neurologic condition24 (28.2)14 (9.0)<.01*
 Chronic respiratory disease5 (5.9)8 (5.1).80
 Heart disease7 (8.2)14 (9.0).85
 Sickle cell/asplenia5 (5.9)17 (10.9).20
Sick contacts33 (38.8)66 (42.9).59
Smokers in household19 (23.8)43 (28.5).53
FLU vaccine38 (54.3)77 (56.2).45
  • *, statistically significant.

  • a Subjects may have had >1 high-risk condition.